Interobserver Reliability and Accuracy of Cranial Ultrasound Scanning Interpretation in Premature Infants
Objective
To assess interobserver reliability between 2 central readers of cranial ultrasound scanning (CUS) and accuracy of local, compared with central, interpretations.
Study design
The study was a retrospective analysis of CUS data from the National Institute of Child Health and Human Development (NICHD) trial of inhaled nitric oxide for premature infants. Interobserver reliability of 2 central readers was assessed with kappa or weighted kappa. Accuracy of local, compared with central, interpretations was assessed by using sensitivity and specificity.
Results
CUS from 326 infants had both central reader and local interpretations. Central reader agreement for grade 3/4 intraventricular hemorrhage (IVH), grade 3/4 IVH or periventricular leukomalacia (PVL), grade of IVH, and degree of ventriculomegaly was very good (kappa = 0.84, 0.81, 0.79, and 0.75, respectively). Agreement was poor for lower grade IVH and for PVL alone. Local interpretations were highly accurate for grade 3/4 IVH or PVL (sensitivity, 87%-90%; specificity, 92%-93%), but sensitivity was poor-to-fair for grade 1/2 IVH (48%-68%) and PVL (20%-44%).
Conclusions
Our findings demonstrate reliability and accuracy of highly unfavorable CUS findings, but suggest caution when interpreting mild to moderate IVH or white matter injury.
Abbreviations: CUS, Cranial ultrasound scanning, INO, Inhaled nitric oxide, IVH, Intraventricular hemorrhage, NICU, Neonatal intensive care unit, PPA, Percent positive agreement, PVL, Periventricular leukomalacia
To access this article, please choose from the options below
Disclosure: INO Therapeutics provided the study gas and gas delivery systems for all hospitals, and capitation funding for the hospitals outside the NICHD Neonatal Research Network that participated in the PiNO trial. The company was not involved in the trial design, data analysis or interpretation, or secondary or ancillary data analysis.The authors have no financial agreement with INO Therapeutics. For funding information, see Appendix II at www.jpeds.com.
PII: S0022-3476(07)00131-X
doi:10.1016/j.jpeds.2007.02.012
© 2007 Mosby, Inc. All rights reserved.
Refers to article:
- Brain Imaging in Neonatal Clinical Trials: In Search of a Gold Standard
